Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Telix Pharmaceutical Ltd (TLX)

37 + Investors. Track Smart Money conviction in TLX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -2
Streak
1Q ▼
Buyers last Q
56%

Smart Money Signals — TLX

Based on 37 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their TLX positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🏔️

At the ownership peak (95% of max)

95% of all-time peak
37 hedge funds hold TLX right now — the highest count in 2.2 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +517% more funds vs a year ago

fund count last 6Q
+31 new funds entered over the past year (+517% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 56% buying

27 buying21 selling
Last quarter: 27 funds bought or added vs 21 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~11 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 16 → 13 → 16 → 11. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔄

Mostly new holders — 70% entered in last year

■ 0% conviction (2yr+) ■ 30% medium ■ 70% new
Only 0 funds (0%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💰

Value +183% but shares only +124% — price-driven

Value
+182%
Shares
+123%
Last quarter: the total dollar value of institutional holdings rose +183%, but actual share count only changed +124%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
➡️

Steady discovery — ~11 new funds/quarter

5 → 16 → 13 → 16 → 11 new funds/Q
New funds entering each quarter: 16 → 13 → 16 → 11. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🌱

Early stage — 95% of holders entered in last year

■ 3% veterans ■ 3% 1-2yr ■ 95% new
Of 37 current holders: 35 (95%) entered in the past year, only 1 (3%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.
✅

Strong quality — 30% AUM from major funds

30% from top-100 AUM funds
6 of 36 holders rank in the top 100 by AUM, accounting for 30% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
6.5
out of 10
Moderate Exit Risk
Exit risk score 6.5/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — TLX

In 2026 Q1, 27 hedge funds were net buyers of TLX (11 opened a new position, 16 added to an existing one), while 21 reduced or exited (8 trimmed, 13 sold completely) — a 56% buyer ratio, indicating a slight buying edge. 30% of total institutional value in TLX is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: -2 funds (more exits than new entries). Total institutional holders: 37.

Hedge Fund Ownership: TLX

How many hedge funds hold TLX — quarterly history vs. share price
Quarterly hedge fund ownership of TLX vs. share price

Market Analysis: TLX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: TLX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Telix Pharmaceutical Ltd (TLX) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much TLX has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 89d ago
TLX
+11.4%
XLV
+9.2%

TLX outperformed XLV by +2.2% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 44d ago
TLX
-1.8%
XLV
+10.3%

Since the filing became public, TLX outperformed XLV by -12.1% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

5 top-rated funds 0 high-conviction
Consensus
3.4
/ 10
breadth
×
Elite
0.2
/ 10
conviction
Hedge Fund Positioning: TLX
37 + Investors

Track Smart Money conviction in TLX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 37 39 -5.13%
13F Shares 3M 1M 123.78%
Total Value $24M $8M 182.92%
New Positions 11 16 -5
Increased Positions 16 11 +5
Closed Positions 13 4 +9
Reduced Positions 8 9 -1
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: TLX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

37 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in TLX. Verified SEC 13F-HR filings.

QUARTER:
Top 25 TLX holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Portland Investment Counsel INC. 0.82% 266,200 $2.5M
2 Portolan Capital Management, LLC 0.28% 541,267 $5.2M
3 XY Capital Ltd 0.12% 12,552 $120K
4 Raiffeisen Bank International AG 0.02% 130,000 $1.2M
5 Integrated Wealth Concepts LLC 0.01% 164,397 $1.6M
6 Private Advisor Group, LLC 0.01% 174,415 $1.7M
7 IHT Wealth Management, LLC 0.01% 25,035 $240K
8 Lazard Asset Management LLC 0.00% 289,917 $2.8M
9 XTX Topco Ltd 0.00% 26,007 $249K
10 Schonfeld Strategic Advisors LLC 0.00% 34,873 $334K
11 Aspect Partners, LLC 0.00% 380 $4K
12 Vident Advisory, LLC 0.00% 16,653 $159K
13 Mariner, LLC 0.00% 43,446 $415K
14 Basecamp Wealth Advisors LLC 0.00% 276 $2K
15 Fmr LLC 0.00% 564,757 $5.4M
16 Larson Financial Group LLC 0.00% 899 $9K
17 CVA Family Office, LLC 0.00% 127 $1K
18 Bell Investment Advisors, Inc 0.00% 70 —
19 Blue Trust, Inc. 0.00% 742 $7K
20 Rhumbline Advisers 0.00% 9,823 $94K
21 Morgan Stanley 0.00% 116,440 $1.1M
22 Mv Capital Management, INC. 0.00% 61 —
23 BNP Paribas Financial Markets 0.00% 12,000 $115K
24 UBS Group AG 0.00% 32,300 $309K
25 Cwm, LLC 0.00% 1,425 $14K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Telix Pharmaceutical Ltd (TLX)

What does the Smart Money Trend signal show for TLX?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their TLX positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for TLX?

Slight buying edge — 56% buying: Last quarter: 27 funds bought or added vs 21 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for TLX holders?

Strong quality — 30% AUM from major funds: 6 of 36 holders rank in the top 100 by AUM, accounting for 30% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held TLX?

Mostly new holders — 70% entered in last year: Only 0 funds (0%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Telix Pharmaceutical Ltd (TLX) following the 2026 Q1 hedge fund 13F filings?

As of today, TLX has moved -1.8% since the 2026 Q1 13F filing date (May 15, 2026), compared to +10.3% for the XLV sector ETF — an outperformance of -12.1%. Since the quarter end (March 31, 2026), TLX has gained +11.4% vs +9.2% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →